Olema Pharmaceuticals
OLMA
Last Price
52 Week Range
$2.86 - $36.26
Next Earnings Date
May 12 2026 (Estimate)
Next Earnings Date
May 12 2026 (Est.)
Last Price
Olema Pharmaceuticals SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Olema Pharmaceuticals, Inc. | 8-K | March 16, 2026 | |
Olema Pharmaceuticals, Inc. | 10-K | March 16, 2026 | |
Olema Pharmaceuticals, Inc. | 8-K | January 30, 2026 | |
Olema Pharmaceuticals, Inc. | 8-K | January 12, 2026 | |
Olema Pharmaceuticals, Inc. | S3ASR | December 11, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | November 19, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | November 18, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | November 10, 2025 | |
Olema Pharmaceuticals, Inc. | 10-Q | November 10, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | October 20, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | September 2, 2025 | |
Olema Pharmaceuticals, Inc. | 10-Q | August 11, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | August 11, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | June 13, 2025 | |
Olema Pharmaceuticals, Inc. | 10-Q | May 13, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | May 13, 2025 | |
Olema Pharmaceuticals, Inc. | DEF 14A | April 28, 2025 | |
Olema Pharmaceuticals, Inc. | DEFA14A | April 28, 2025 | |
Olema Pharmaceuticals, Inc. | ARS | April 28, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | March 18, 2025 | |
Olema Pharmaceuticals, Inc. | 10-K | March 18, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | March 5, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | January 13, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | January 10, 2025 | |
Olema Pharmaceuticals, Inc. | 8-K | December 10, 2024 | |
Olema Pharmaceuticals, Inc. | 8-K | December 2, 2024 | |
Olema Pharmaceuticals, Inc. | 10-Q | November 12, 2024 | |
Olema Pharmaceuticals, Inc. | 8-K | November 12, 2024 | |
Olema Pharmaceuticals, Inc. | 8-K | September 27, 2024 | |
Olema Pharmaceuticals, Inc. | 10-Q | August 6, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.